Search

everythinglearnresearchcommunity

for

Search:↓

IVL-DrugFluidic® can mass-produce high-quality, long-acting injectable drug microspheres, improving patient compliance and reducing side effects.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

Phyllanthus emblica leaves show potential for developing new antimalarial drugs with low toxicity.

Many patients with lower urinary tract symptoms also have undiagnosed erectile dysfunction, which improves with treatment.

Dupilumab effectively treats various inflammatory skin diseases beyond its initial use for atopic dermatitis.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

Bicalutamide improves hair density in women safely.

Ruxolitinib cream may help treat severe hair loss in children.

The antibody 005-C04 blocks prolactin receptors, causing reversible infertility, impaired lactation, and hair regrowth in female mice.

New tests detect finasteride and dutasteride in urine quickly and easily.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

A new method effectively analyzes Finasteride and its impurities, even under stress conditions.

Mefloquine was generally safe at 500 mg weekly, but higher doses caused nausea and diarrhea.

Quickly get finasteride from tablets using easy methods.

Quick, selective detection of tadalafil and finasteride in human plasma developed.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Dutasteride effectively treats benign prostatic hyperplasia and may reduce prostate cancer risk.

Researchers developed a quick and accurate method to measure finasteride and tamsulosin in tablets.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Cyproterone acetate effectively treats virilized women, especially under 35, despite some side effects.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

New treatments for Hepatitis C show promise but need more research to confirm their safety and effectiveness for clinical use.

Bicalutamide does not significantly affect liver enzymes and is a safe anti-androgen option for transfeminine individuals.

Combining tadalafil and finasteride improves their solubility and effectiveness.